Pete. Thanks,
our Slide financial start Let's on X. performance with
of flat quarter's chain first supply the the strong billion results this For quarter benefited which organically double-digit China stimulus we and growth conditions approximately XXXX, of followed of revenues the first easing year-over-year. Recall, strong from in were $X.X XXXX, quarter sales. delivered
increased dollars we to X% a book-to-bill total year-over-year, sales, U.S., X.XXx company of in orders solid primarily outpace by Organic continuing with orders strength X.XXx driven the versus generated last year.
the EBIT points exited quarter SG&A. also billion. margin profit backlog with XX.X%, a with year-over-year, healthy $XX.X improvements both first and XX basis margin gross We in was up of Adjusted
expense. interest declined year-over-year, service closer was the grew year. On at performance revenue revenue was up last improved in margins look from reported period quarter. cash lower and revenue in free $XXX X% the growth approximately by On flow EPS we adjusted capital. X%. product versus quarter X% company for X, first we And generated improved total First and $X.XX, a same Organic flat that take the a Slide XX% generated basis, let's driven million working
the quarter. low a given as first benefited China comparison. XXXX the that in including by impacted double Longer of the revenue larger base. service the term, growth well digits in we Product difficult see opportunities declined performance as good greater service, both from quarter product year-over-year was and anticorruption revenue installed impact stimulus
up sales results. year U.S. sales and the slightly rest EMEA world flat of were prior with and in were
we Slide and to Adjusted productivity gross margin quarter initiatives. first points the margin initiatives. wins X expanded benefited on progress made as in and commercial we the from Turning XXX basis
also our teams for to practices delivered quarter. an price in continue Productivity the ongoing improvements. positive is We lean and focus our drive
while are expanding teams work to new daily and standard Our management on current commitments. areas delivering
segments All as made investments product strategic technologies, to segments productivity improvements. variable and XD quality and capabilities delivered across greater variable improve and printing manufacturing cost platforming been productivity. of our and mid-single advanced such making cost or digit in Additive, significant We've our enhance
company [ To and than any date investments with have These drive ]. patents in the lower U.S., more XD XX other cost durability. printing-related we imaging higher
we're MR, than and entire these year across $X reliability. improving million in saving example, methodologies more a and performance portfolio, the For applying us
continue with exited in make progress EBIT us we majority TSAs This agreements and spin, we're allow since cost the strategic well progress to We this optimize adjusted and to SG&A, for in continuing to roughly expansion On positioned while gross further priorities future of future. remaining year. to the growth. XXX solid vast margin our fund the margin exit delivered structure will
turn I'll to our Now segments.
where on EBIT through with approximately rate year XXX contract while start price basis against margin sales XX%. up enhancing the growth. we made was service was to Let's productivity, gross were year-over-year. capture difficult a Imaging organic margin when investing revenue in This progress prior points and Segment We on R&D. had flat comparison Slide X, up
margin. for Margin the the expansion plans track and Day. we guidance. and revenue Imaging Investor are introductions critical for new impact therapies products remains to our Precision remains business we're on demand to both our for future about product as us, Imaging in expected excited this Customer the our healthy have priority on at drive communicated need We're a new
Segment Turning to Ultrasound inflation basis growth points lower margin and driven volume. Organic on year-over-year, decreased Slide in primarily X% revenue was EBIT down year-over-year, double-digit year. X. the prior following XXX by
ongoing pricing platforms, strategies helped focus with During and along team's strong challenges. the these commonality offset quarter, the productivity to standardization through partially on across
Looking ahead.
as exciting new growth well ultrasound drive improvements and as expect also to the the will line margin solid, several launched year. Our we productivity top accelerate notably, half performance. to innovations in second bottom that Most recently benefit and both of initiatives funnel is we
Patient volume X. COVID-related driven down to which healthy, us basis revenue points and for inflation Moving China, timing delays growth year year-over-year, fulfillment EBIT of well due in Segment ventilator Solutions shipments. Organic decreased and Backlog X% prior by margin year-over-year, primarily was to remains which Care on Slide year. in-quarter XXX drove last double-digit positions growth.
quarters. to programs expect we implemented will in our that productivity drive We margin price future and improve
and Slide growth. countries. we In second strong continued signs Alzheimer's growth, in sales of half progress saw with price volume the expect and another Moving other the by the substantial uptick to We quarter approvals, encouraging therapy year-over-year organic of additional had XXXX. the quarter, increases more Diagnostics XX. on Pharmaceutical Vizamyl generating we With driven first in from U.S. X%
and XXX We're of driven robust Segment the improved basis year-over-year, XX% encouraged also continue on continued strength price, volume EBIT global strengthen Imaging of invest drives points security our patients' and needs. of capacity our in executing which by for R&D nearly productivity our actions margin we by our procedures, pipeline. supply mostly to while the the deliver significant on to customers for agents. to investments need We're
customers lean expected Norway chain. capacity to time, delivering be Lindesnes methodology our for completed foundational our we our second dose facility increase At as to the the during to is quarter. patient is in across at continue expansion our Planned same supply
the Slide million. I'll to Turning we In cash our flow through flow $XXX cash delivered XX, walk performance. first free quarter, of
the receivable. lower reflected improved year-over-year inventory and working associated accounts processes collection our priorities and efforts and management drive improved Our and progress Many inventory turns helped our lean capital of here. with
cash accelerate for and innovation. generation, capabilities future strong M&A to us with flexibility the support Our to leaving provides opportunistic growth, room organic financial
disclosed, our $XXX down in balance paying previously debt strengthened As we of million the by quarter. sheet
full In turn outlook let's Slide year XX. on are our we XXXX Now short, our guidance. to reaffirming
improvement quarter We organic sales modest margin. in expect growth second adjusted EBIT and sequential a
discussed of support our the the a in second growth revenue we There half will quarter the catalysts stronger As year. adjusted that fourth growth of margin through in year. few call, are the rest EBIT and expect
includes launches accelerate of in new growth that product This number a will ultrasound.
healthy expect addition, order we imaging backlog in a In see supported by and funnel. to large growth
our in trends quarter the to challenges healthy we resolve continued PCS, first have the by midyear. backlog expect expect procedure PDx fulfillment And in as business strong. growth in remain and We
that, Pete. turn call to With back over I'll the
